Evidence map›Paper›PMID 25343521›Full record

ArticlePloS one2014

Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study.

Peter Gresner, Jolanta Gromadzinska, Ewa Jablonska, Maciej Stepnik, Oscar Zambrano Quispe, Ewa Twardowska, Wojciech Wasowicz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Peter GresnerDepartment of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland.
Jolanta GromadzinskaDepartment of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland.
Ewa JablonskaDepartment of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland.
Maciej StepnikDepartment of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland.
Oscar Zambrano QuispeDepartment of Oncology, Herlev Hospital, Herlev, Denmark.
Ewa TwardowskaDepartment of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland.
Wojciech WasowiczDepartment of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, Lodz, Poland.
Nofer Institute of Occupational Medicine · PLHerlev Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deleterious and missense mutations of RAD51C have recently been suggested to modulate the individual susceptibility to hereditary breast and ovarian cancer and unselected ovarian cancer, but not unselected breast cancer (BrC). We enrolled 132 unselected BrC females and 189 cancer-free female subjects to investigate whether common single nucleotide polymorphisms (SNPs) in non-coding regions of RAD51C modulate the risk of BrC, and whether they affect the level of oxidative stress and the extent/characteristics of DNA damage. Neither SNPs nor reconstructed haplotypes were found to significantly affect the unselected BrC risk. Contrary to this, carriers of rs12946522, rs16943176, rs12946397 and rs17222691 rare-alleles were found to present significantly increased level of blood plasma TBARS compared to respective wild-type homozygotes (p<0.05). Furthermore, these carriers showed significantly decreased fraction of oxidatively generated DNA damage (34% of total damaged DNA) in favor of DNA strand breakage, with no effect on total DNA damage, unlike respective wild-types, among which more evenly distributed proportions between oxidatively damaged DNA (48% of total DNA damage) and DNA strand breakage was found (p<0.0005 for the difference). Such effects were found among both the BrC cases and healthy subjects, indicating that they cannot be assumed as causal factors contributing to BrC development.

Indexed as

Genetic Predisposition to DiseaseAdultAgedAged, 80 and overBreast NeoplasmsCase-Control StudiesDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA DamageDNA, IntergenicFemaleGene FrequencyGenetic Association StudiesHaplotypesHumansLinkage DisequilibriumDNA-Binding ProteinsDNA, IntergenicRAD51C protein, humanThiobarbituric Acid Reactive Substances

Identifiers

PMID25343521
PMCPMC4208807
OpenAlexW2019805371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.